Your browser doesn't support javascript.
Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy.
Valletta, Martina; Canevelli, Marco; D'Antonio, Fabrizia; Trebbastoni, Alessandro; Talarico, Giuseppina; Campanelli, Alessandra; Sepe Monti, Micaela; Di Vita, Antonella; Salati, Emanuela; Imbriano, Letizia; Margiotta, Roberta; Barbetti, Sonia; Diana, Sofia; Buscarnera, Simona; Toccaceli Blasi, Marco; Salzillo, Martina; Pugliese, Giuseppe; Vanacore, Nicola; Bruno, Giuseppe.
  • Valletta M; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Canevelli M; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • D'Antonio F; National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.
  • Trebbastoni A; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Talarico G; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Campanelli A; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Sepe Monti M; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Di Vita A; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Salati E; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Imbriano L; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Margiotta R; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Barbetti S; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Diana S; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Buscarnera S; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Toccaceli Blasi M; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Salzillo M; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Pugliese G; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Vanacore N; Department of Human Neuroscience, "Sapienza" University, Rome, Italy.
  • Bruno G; National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.
J Alzheimers Dis ; 87(4): 1467-1474, 2022.
Article in English | MEDLINE | ID: covidwho-1892597
ABSTRACT
This study aimed to explore the prevalence and safety of SARS-CoV-2 vaccination in individuals with dementia. Patients with mild cognitive impairment or dementia were recruited at a tertiary memory clinic, from March 15 to September 15, 2021. Information on COVID-19 vaccination and adverse events experienced after vaccine administration were collected from caregivers. Two-hundred-seventy subjects were finally recruited. Among them, 253 (93.7%) had received the vaccine and only 69 (27.3%) experienced adverse events. Cognitive and behavioral changes following immunization were only rarely reported. COVID-19 vaccination is safe and well-tolerated in patients with cognitive impairment who should be prioritized in the vaccination campaign.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Dementia / COVID-19 Type of study: Observational study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: J Alzheimers Dis Journal subject: Geriatrics / Neurology Year: 2022 Document Type: Article Affiliation country: JAD-220077

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Dementia / COVID-19 Type of study: Observational study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: J Alzheimers Dis Journal subject: Geriatrics / Neurology Year: 2022 Document Type: Article Affiliation country: JAD-220077